Clinical Trial

A Study to Test the Safety and Tolerability of Brivaracetam in Children and Adolescents With Seizures

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The purpose of the study is to evaluate the long-term safety and tolerability of brivaracetam.
Protocol Amendment History 38 amendments
This ClinicalTrials.gov record has been amended 38 times since 2021-01-19; most recent amendment 2026-07-24.
Status change: Active, Not Recruiting → Recruiting 2025-06-03
Status change: Recruiting → Active, Not Recruiting 2022-04-25
Status change: Not Yet Recruiting → Recruiting 2021-03-16
Trial Details
NCT Number NCT04715646
Lead Sponsor UCB Biopharma SRL
Conditions Epilepsy
Enrollment 70 participants
Start Date 2021-03-11
Primary Completion 2030-07-08 (estimated)
Study Completion 2030-07-08 (estimated)
Updated on ClinicalTrials.gov 2026-07-27